GL2702 GLARS-NF1tablet

· GL Pharm Tech Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GL2702 GLARS-NF1tablet, covering 2016-02-25 to 2016-02-25. Get the full timeline:

Most recent: Clinical Trial Update: Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTS [Phase 3]

See pricing